Evidence map›Paper›PMID 29173174›Full record

ReviewCurrent neuropharmacology2018

Autophagy after Subarachnoid Hemorrhage: Can Cell Death be Good?

Wing-Mann Ho, Onat Akyol, Haley Reis, Cesar Reis, Devin McBride, Claudius Thome, John Zhang

Open access · bronzeAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wing-Mann HoDepartment of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.
Onat AkyolDepartment of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, United States.
Haley ReisLoma Linda University School of Medicine, Loma Linda, United States.
Cesar ReisDepartment of Preventive Medicine, Loma Linda University School of Medicine, Loma Linda, United States.
Devin McBrideDepartment of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, United States.
Claudius ThomeDepartment of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.
John ZhangDepartment of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, United States.
Loma Linda University · USUniversität Innsbruck · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutophagy is a prosurvival, reparative process that maintainsww cellular homeostasis through lysosomal degradation of selected cytoplasmic components and programmed death of old, dysfunctional, or unnecessary cytoplasmic entities. According to growing evidence, autophagy shows beneficial effects following subarachnoid hemorrhage (SAH). SAH is considered one of the most devastating forms of stroke.

methodsIn this review lies in revealing the pathophysiological pathways and the effects of autophagy. Current results from animal studies will be discussed focusing on the effects of inhibitors and inducers of autophagy. In addition, this review discusses the clinical translation of potential neuropharmacological targets that can help prevent early brain injury (EBI) following SAH by incorporating programmed cell death into clinical management.

resultsPublished data showed that autophagy mechanisms have a prosurvival effect to reduce apoptotic cell death after SAH. However, if SAH exceeds a certain stress threshold, autophagy mechanisms lead to increased apoptotic cell death, more brain injury, and worse outcome.

conclusionFuture investigation on the differences and molecular switches between protective mechanisms of autophagy and excessive "self-eating" autophagy leading to cell death is needed to achieve more insight into the complex pathophysiology of brain injury after SAH. If autophagy after SAH can be controlled to lead to beneficial effects only, as the physiological self-control mechanism, this could be an important target for treatment.

Indexed as

AutophagyAnimalsHumansNeuroprotectionSubarachnoid Hemorrhageautophagosomeautophagybrain injurycell deathlysosomeneuroprotection.Subarachnoid hemorrhage

Identifiers

PMID29173174
PMCPMC6251054
OpenAlexW2769297716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.